Efficacy and Duration of Pain Relief in Transforaminal and Lumbar Sympathetic Blocks
Launched by BEZMIALEM VAKIF UNIVERSITY · May 27, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how adding a specific type of pain relief treatment, called lumbar sympathetic blockade, can help patients manage their pain after they have received other treatments for low back pain, such as epidural steroid injections. The focus is on patients who have had issues like lumbar disc herniation, which is when a disc in the spine bulges out and causes pain. Researchers want to see if this additional treatment can improve pain relief and how long that relief lasts.
To participate in this study, you need to be between the ages of 18 and 80 and have had a specific injection for your back pain. However, there are some important reasons why someone might not be able to join, such as having allergies to the medications used, certain medical conditions, or if you're pregnant or breastfeeding. If you do join, you can expect to receive the treatments being studied and be monitored for your pain levels to see how well the combination of treatments works for you. This research aims to find better ways to help people like you manage low back pain effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ASA I-II-III
- • Patients who underwent facet joint injection and transforaminal injection due to lumbar disc herniation
- Exclusion Criteria:
- • Patients with known allergies to the drugs to be used in treatment
- • Infection near the puncture site
- • Known coagulation disorders
- • Patients with internal fixation or severe anatomical variation such as scoliosis and tumor
- • History of sympathetic chemical or thermal neurolysis
- • Alcohol and drug use
- • Disorder of consciousness
- • Liver failure, renal failure, advanced cardiac failure
- • Uncontrolled diabetes mellitus
- • Morbid obesity (body mass index (BMI) \> 35 kg m-2)
- • Female patients during pregnancy and breastfeeding
- • Not approving the informed consent form
About Bezmialem Vakif University
Bezmialem Vakif University is a prominent academic institution based in Istanbul, Turkey, dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its state-of-the-art facilities and a multidisciplinary team of experts to conduct innovative research that aims to improve patient outcomes and enhance therapeutic strategies. Bezmialem Vakif University is committed to adhering to rigorous ethical standards and regulatory guidelines, ensuring the integrity and reliability of its clinical trials while fostering collaboration with global research communities. Through its initiatives, the university seeks to contribute significantly to the field of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Istanbul, , Turkey
Patients applied
Trial Officials
Zübeyde Özdemir
Study Chair
ethics committee chairman
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported